Last checked at Astra's Enhertu Gets Breakthrough Status In US, Bevespi OK'd In China
Astra's Enhertu Gets Breakthrough Status In US, Bevespi OK'd In China
18 May 20 08:17
- Home
- Share Prices
- AQSE Share Prices
- Share Chat
- FX
- News
- Blogs
- RNS
- Media
- Brokers
- Finance Tools
- Members
Latest Share Chat
Astrazeneca Share News (AZN)
AZN Share
Price
AZN Share
News14
AZN Share
Chat9
AZN Share
Trades22,077
AZN
Live RNS
AZN Share
Charts
AZN Level 2
Console
AZN Live
Share Price
AZN Broker
Ratings
AZN Directors
Deals
AZN Financial
Diary
AZN
Fundamentals
AZN Short
Positions
AZN
Media
AZN Information
Share Price Information for Astrazeneca (AZN)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
7,103.00
Bid:
7,102.00
Ask:
7,104.00
Change:
-33.00
(-0.46%)
Spread:
2.00 (0.03%)
Open:
7,030.00
High:
7,116.00
Low:
7,001.00
Yest. Close:
7,136.00
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.18 May 20 08:17AstraZeneca clears regulatory hurdles for Enhertu and Bevespi Aerosphere
(Sharecast News) - AstraZeneca, alongside its partner Daiichi Sankyo, announced on Monday that 'Enhertu', or trastuzumab deruxtecan, has been granted breakthrough therapy designation in the United States.
18 May 20 07:25UPDATE 2-UK coronavirus death toll rises by 170, lowest increase since March
(Adds Oxford University deal with AstraZeneca)LONDON, May 17 (Reuters) - The number of people who have died in the United Kingdom after testing positive for COVID-19 rose by 170 to 34,636, business minister Alok Sharma said on Sunday, the lowest i...
17 May 20 17:10Oxford coronavirus vaccine found protective in small monkey study
By Julie SteenhuysenMay 14 (Reuters) - A closely watched coronavirus vaccine being developed by scientists at Oxford University appears protective in a small study of six monkeys, promising findings that led to the start of human trials late last ...
14 May 20 18:35LIVE MARKETS-EZ industrial production: Long way back to 2017 highs
* European shares slump on virus fears* Banks hit by earnings* EZ industry output suffers record fall in March Welcome to the home for real-time coverage of European equity markets brought to you by Reuters stocks reporters. You can share your thou...
13 May 20 12:48LIVE MARKETS-When will a vaccine be ready? Here's a guess!
* European shares slump on virus fears* Banks hit by earnings* EZ industry output suffers record fall in March Welcome to the home for real-time coverage of European equity markets brought to you by Reuters stocks reporters. You can share your thou...
13 May 20 11:58Monday broker round-up
(Sharecast News) - Diploma: Peel Hunt downgrades to hold with a target price of 1,650p.
11 May 20 13:48UK BROKER RATINGS SUMMARY: Goldman Sachs Cuts Next To Neutral From Buy
UK BROKER RATINGS SUMMARY: Goldman Sachs Cuts Next To Neutral From Buy
11 May 20 09:33AstraZeneca Secures US Approvals, Recovers Rights To Brazikumab
AstraZeneca Secures US Approvals, Recovers Rights To Brazikumab
11 May 20 09:25LONDON MARKET PRE-OPEN: Diploma And Victrex Pull Interim Dividends
LONDON MARKET PRE-OPEN: Diploma And Victrex Pull Interim Dividends
11 May 20 07:46AstraZeneca upbeat on developments for Lynparza, Enhertu
(Sharecast News) - AstraZeneca, alongside its partner MSD, announced on Monday that 'Lynparza', or olaparib, in combination with bevacizumab has been approved in the United States for the maintenance treatment of adult patients with advanced epithelial ovarian, fallopian tube or primary peritoneal cancer.
11 May 20 07:29UPDATE 1-GSK to test experimental drug to treat pneumonia from COVID-19
(Adds background, mode of action, previous pacts)By Ludwig BurgerMay 7 (Reuters) - GlaxoSmithKline will start trials of an experimental rheumatoid arthritis drug on patients suffering from pneumonia related to COVID-19 at the end of the month.Havi...
7 May 20 16:54Cigna's Express Scripts offers discounted drugs for U.S. newly unemployed
NEW YORK, May 7 (Reuters) - Express Scripts is offering discounted $25 and $75 prescription drug prices to the newly uninsured, a stop-gap measure aimed at Americans who lose their jobs and health insurance due to the coronavirus pandemic.The U.S....
7 May 20 10:00LONDON MARKET CLOSE: Stocks Mixed Amid Grim US Jobs Report
LONDON MARKET CLOSE: Stocks Mixed Amid Grim US Jobs Report
6 May 20 17:19UPDATE 2-European shares hobbled by record recession forecast, ECB concerns
* European Commission sees record euro zone recession in 2020* Healthcare stocks steady on AstraZeneca boost* Risk seen that PEPP might be challenged - Economist* Oil and gas sector leads declines (Adds details, updates to close)By Sruthi Shankar a...
6 May 20 10:23